Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Antiaging Quantum Living (AAQL) Cash & Equivalents (2020 - 2025)

Antiaging Quantum Living (AAQL) has disclosed Cash & Equivalents for 6 consecutive years, with $936910.0 as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 362.7% to $936910.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $936910.0 through Dec 2025, up 362.7% year-over-year, with the annual reading at $370549.0 for FY2025, 122.48% up from the prior year.
  • Cash & Equivalents hit $936910.0 in Q4 2025 for Antiaging Quantum Living, up from $455446.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $936910.0 in Q4 2025 to a low of $354.0 in Q1 2023.
  • Historically, Cash & Equivalents has averaged $157851.1 across 5 years, with a median of $48172.0 in 2021.
  • Biggest five-year swings in Cash & Equivalents: crashed 97.48% in 2021 and later soared 46948.59% in 2024.
  • Year by year, Cash & Equivalents stood at $15494.0 in 2021, then tumbled by 94.18% to $901.0 in 2022, then skyrocketed by 13845.39% to $125648.0 in 2023, then skyrocketed by 61.15% to $202487.0 in 2024, then soared by 362.7% to $936910.0 in 2025.
  • Business Quant data shows Cash & Equivalents for AAQL at $936910.0 in Q4 2025, $455446.0 in Q3 2025, and $405725.0 in Q2 2025.